Therapy for chronic cold agglutinin disease: perspective for further improvements.
作者信息
Berentsen Sigbjørn
出版信息
Blood Transfus. 2013 Apr;11(2):167-8. doi: 10.2450/2013.0273-12. Epub 2013 Jan 22.
Abstract
摘要
相似文献
1
Therapy for chronic cold agglutinin disease: perspective for further improvements.
Blood Transfus. 2013 Apr;11(2):167-8. doi: 10.2450/2013.0273-12. Epub 2013 Jan 22.
2
Efficacy of rituximab-bendamustine in cold agglutinin haemolytic anaemia refractory to previous chemo-immunotherapy: a case report.
Blood Transfus. 2013 Apr;11(2):311-4. doi: 10.2450/2012.0166-12. Epub 2013 Jan 22.
3
[Alleviated anemia by bendamustine in cold agglutinin disease associated with small lymphocytic lymphoma].
Rinsho Ketsueki. 2015 Feb;56(2):204-9. doi: 10.11406/rinketsu.56.204.
4
Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).
Am J Hematol. 2015 Mar;90(3):204-7. doi: 10.1002/ajh.23909. Epub 2015 Jan 16.
5
Improvement of the thermal amplitude after rituximab treatment for cold agglutinin disease with Waldenström's macroglobulinemia.
Ann Hematol. 2010 Jan;89(1):103-4. doi: 10.1007/s00277-009-0773-z. Epub 2009 Jun 10.
6
[Efficacity of rituximab in hemolytic anemia with cold autoantibodies case].
Ann Pharm Fr. 2011 Jul;69(4):205-8. doi: 10.1016/j.pharma.2011.06.002. Epub 2011 Jul 19.
7
HBV reactivation in malignant lymphoma patients treated with rituximab and bendamustine.
Int J Hematol. 2012 May;95(5):588-91. doi: 10.1007/s12185-012-1050-9. Epub 2012 Mar 16.
8
9
Successful rituximab therapy in the treatment of refractory cold haemagglutinin disease with long-term disease control.
Intern Med J. 2010 May;40(5):387-9. doi: 10.1111/j.1445-5994.2010.02173.x.
10
[Successful treatment with rituximab in a patient with refractory mixed-type autoimmune hemolytic anemia].
Rinsho Ketsueki. 2013 Nov;54(11):2053-5.
本文引用的文献
1
Efficacy of rituximab-bendamustine in cold agglutinin haemolytic anaemia refractory to previous chemo-immunotherapy: a case report.
Blood Transfus. 2013 Apr;11(2):311-4. doi: 10.2450/2012.0166-12. Epub 2013 Jan 22.
2
Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia.
Blood Rev. 2012 May;26(3):107-15. doi: 10.1016/j.blre.2012.01.002. Epub 2012 Feb 12.
3
Classification and therapeutic approaches in autoimmune hemolytic anemia: an update.
Expert Rev Hematol. 2011 Dec;4(6):607-18. doi: 10.1586/ehm.11.60.
4
How I manage cold agglutinin disease.
Br J Haematol. 2011 May;153(3):309-17. doi: 10.1111/j.1365-2141.2011.08643.x. Epub 2011 Mar 8.
5
Heating up cold agglutinins.
Blood. 2010 Oct 28;116(17):3119-20. doi: 10.1182/blood-2010-07-297523.
6
High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease.
Blood. 2010 Oct 28;116(17):3180-4. doi: 10.1182/blood-2010-06-288647. Epub 2010 Jul 15.
7
Balancing risk versus benefit in the treatment of Waldenström's Macroglobulinemia patients with nucleoside analogue-based therapy.
Clin Lymphoma Myeloma. 2009 Mar;9(1):71-3. doi: 10.3816/CLM.2009.n.018.
8
Hemolytic anemia due to warm autoantibodies.
Blood Rev. 2008 Jan;22(1):17-31. doi: 10.1016/j.blre.2007.08.001. Epub 2007 Sep 27.
9
Primary chronic cold agglutinin disease: a population based clinical study of 86 patients.
Haematologica. 2006 Apr;91(4):460-6.
10
Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients.
Leuk Lymphoma. 2006 Feb;47(2):253-60. doi: 10.1080/10428190500286481.
Zotero 插件